Volume 32, Number 3—March 2026
Research Letter
Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017
Figure 2

Figure 2. Cost ratios before and after extrapulmonary nontuberculous mycobacterial disease diagnosis, Denmark, 2005–2017. A) Total direct healthcare costs; B) employment income; C) total public benefits. Ratios adjusted for Charlson comorbidity index and educational level; values above 1 (dotted horizontal line) indicate higher costs for cases than comparators. Solid center lines indicate average cost; shaded areas with borders indicate 95% CIs.
Page created: February 09, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.